NCT03408002 (PREPARE) is a NA clinical trial of Psychological intervention in Anxiety Disorder, sponsored by Azienda Ospedaliera Universitaria Integrata Verona.

Who is sponsoring NCT03408002?

NCT03408002 is sponsored by Azienda Ospedaliera Universitaria Integrata Verona.

What drugs are being tested in NCT03408002?

Interventions in NCT03408002: Psychological intervention.

What condition does NCT03408002 study?

NCT03408002 studies Anxiety Disorder, Surgery.

Is NCT03408002 still recruiting?

NCT03408002 is currently completed. Last updated 21 June 2019.

Last reviewed 2019-06-21 · How we verify

NCT03408002: PREPARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PREPARE - PREoPerative Anxiety REduction

Completed NA Last updated 21 June 2019

What this trial tests

NA trial testing Psychological intervention in Anxiety Disorder in 400 participants. Completed in 30 December 2018.

Timeline

14 June 2017

Primary endpoint
15 June 2018

30 December 2018

Quick facts

Lead sponsor	Azienda Ospedaliera Universitaria Integrata Verona
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	400
Start date	14 June 2017
Primary completion	15 June 2018
Estimated completion	30 December 2018
Sites	1 location across Italy

Drugs / interventions tested

Psychological intervention

Conditions studied

Anxiety Disorder — all drugs for Anxiety Disorder →
Surgery — all drugs for Surgery →

Sponsor

Azienda Ospedaliera Universitaria Integrata Verona — full company profile →

Who can join

Adults 18 to 80, any sex, with Anxiety Disorder or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to verify if a short individual psychological intervention might increase perceived self-efficacy in managing preoperative anxiety in patients who will undergo pancreatic surgery. It is a randomized clinical trial where half of participants will attend a psychological intervention based on "the four elements protocol" by Elan Shapiro the day before surgery, while the other half will follow usual care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

PREPARE: PreoPerative Anxiety REduction. One-Year Feasibility RCT on a Brief Psychological Intervention for Pancreatic Cancer Patients Prior to Major Surgery.
Marinelli V, Danzi OP, Mazzi MA, Secchettin E, et al · · 2020 · cited 33× · PMID 32194490 · DOI 10.3389/fpsyg.2020.00362

Verify or expand the search:

Other trials of Psychological intervention

Trials testing the same drug.

NCT07017127 — Remission of Type 2 Diabetes With Lifestyle Intervention · NA · recruiting
NCT06830967 — Virtual Prehabilitation for Patients Undergoing Abdominal Aortic Aneurysm Repair · NA · not yet recruiting
NCT06302309 — Tackling Anxiety-related Freezing of Gait in People With Parkinson's Disease · NA · completed
NCT06318572 — Development of Self-administrable Psychological Intervention Programs Supported by New Technologies as a Treatment for P · NA · unknown
NCT04789694 — Prehabilitation in Gynaecological Cancer Patients · Phase 3 · recruiting

Other recruiting trials for Anxiety Disorder

Currently open trials in the same condition.

NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
NCT07221409 — Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment · NA · recruiting
NCT07045818 — DLPFC and Sympathetic Reactivity in RPL With Anxiety · recruiting
NCT05232032 — Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation · Phase 2 · recruiting
NCT06333925 — Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study · NA · active not recruiting

Other Azienda Ospedaliera Universitaria Integrata Verona trials

Trials by the same sponsor.

NCT07325877 — Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis · NA · not yet recruiting
NCT07289035 — Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. · Phase 2 · not yet recruiting
NCT07186582 — Verona Coronary Physiology Interventional Registry · active not recruiting
NCT06820541 — Gallbladder Stenting in FC-SEMS · NA · not yet recruiting
NCT07338708 — Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03408002 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Universitaria Integrata Verona
Last refreshed: 21 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03408002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing